Cryptococcal Meningitis
📧 Sign up to get email alerts when something new happens for Cryptococcal Meningitis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2011-03-07FDA Approved: FLUCONAZOLE — Original Application (ANI Pharmaceuticals, Inc.)
ANI Pharmaceuticals received FDA approval for an original generic application of fluconazole.
-
CLINICAL_TRIALS trial_result · 2010-06-23Clinical Trial Update: Amphotericin Alone or in Combination With Fluconazole for AIDS-Associated Meningitis [Phase 2]
A Phase 2 trial comparing amphotericin B alone versus amphotericin B combined with fluconazole for AIDS-associated cryptococcal meningitis c…
-
FDA approval · 2010-03-05FDA Approved: AMPHOTERICIN B — Supplemental Application (XGen Pharmaceuticals DJB, Inc.)
FDA approved a supplemental application for Amphotericin B submitted by XGen Pharmaceuticals DJB, Inc. This approval authorizes a change to …
-
FDA approval · 2009-09-18FDA Approved: FLUCONAZOLE — Original Application (Rising Pharma Holdings, Inc.)
FDA approved the original application for fluconazole from Rising Pharma Holdings, Inc., enabling the generic antifungal to enter the market…
-
FDA approval · 2009-07-30FDA Approved: FLUCONAZOLE — Original Application (Hospira, Inc)
FDA approved Hospira's original application for a generic fluconazole product, an antifungal medication with indications similar to the refe…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-06-03Clinical Trial Update: Safety and Antifungal Activity of Recombinant Interferon-Gamma 1b (rIFN-Gamma 1b) Given With Standard Therapy in Patients With Cryptococcal Meningitis [Phase 2]
Phase 2 trial evaluating the safety and antifungal activity of recombinant interferon-gamma 1b added to standard therapy in cryptococcal men…
-
CLINICAL_TRIALS trial_result · 2009-02-19Clinical Trial Update: Efficacy and Safety of Mycograb as Adjunctive Therapy for Cryptococcal Meningitis in Patients With AIDS [Phase 2]
Phase 2 trial update evaluating the efficacy and safety of Mycograb as adjunctive therapy for cryptococcal meningitis in AIDS patients; the …
-
CLINICAL_TRIALS trial_result · 2008-12-12Clinical Trial Update: Efficacy and Safety of Mycograb as Adjunctive Therapy for Cryptococcal Meningitis in Patients With AIDS [Phase 2]
Phase 2 trial evaluating the efficacy and safety of Mycograb as adjunctive therapy for cryptococcal meningitis in AIDS patients has been ter…
-
FDA approval · 2006-08-10FDA Approved: ANCOBON — Supplemental Application (Bausch Health US LLC)
FDA approved a supplemental application for ANCOBON (flucytosine) submitted by Bausch Health US LLC.
-
FDA label_change · 2006-05-19FDA Approved: VFEND — Supplemental Application (Roerig)
FDA approved a supplemental application for VFEND (voriconazole) submitted by Roerig, updating the product labeling.